Pharma News, 2025

OS will now seek approval for OST-HER2’s in the indication throughout the UK, US and EU. OS Therapies’ cancer vaccine, OST-HER2, has offered improvements to overall survival (OS) in a Phas...

Three scientists win Nobel Prize in chemistry for creating new molecular structure

Boehringer bags FDA okay for new pulmonary fibrosis drug

CAMBRIDGE, Mass. - Editas Medicine, Inc., whose stock has surged over 260% in the past six months according to InvestingPro data

China-based companies are responsible for 20% of drugs in development globally, reflecting the powerhouse role the country has embraced in the pharmaceutical industry.

Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy

AstraZeneca and Daiichi’s Datroway trumps chemo in first-line breast cancer

McMaster University and MIT discover new antibiotic for IBD

Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB)

IGC Pharma's Preclinical Data for IGC-1C: New Drug Candidate Potentially Disrupts a Foundational Mechanism of Alzheimer's Disease

Engineered IL-21 cytokine mimic enhances antitumour immunity in preclinical models

FDA announced a new pilot program designed to provide faster reviews for domestically tested and manufactured generic drugs.